JAMP Digoxin tablets: One lot recalled due to possible oversized tablets which may pose overdose risk
Recalled Product
JAMP Digoxin 0.0625 mg tablets (lot EG23DGX001, expiry 07-2025)
Hazard / Issue
Product safety
Issued by
Communications and Public Affairs Branch
⚠️ What You Should Do
Return your JAMP Digoxin 0.0625 mg tablets to your pharmacy for replacement as soon as possible. Until you can return them, continue to take your JAMP Digoxin but do not take tablets that look oversized (see image, which shows an oversized tablet on the left and proper-sized tablet on the right). If you are unsure whether your product is affected, check with your pharmacy.Contact a health care professional immediately if you or someone you are caring for experience serious side effects.Contact JAMP Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at custjamp@jamppharma.com, if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.Additional information for health professionals: Health care professionals, such as pharmacists, should check bottles of JAMP Digoxin 0.0625 mg tablets before dispensing and report any unusual tablets to the company and to Health Canada.
Were you affected by this recall?
If you were harmed by a recalled product, you may have legal options. Consider speaking with a consumer protection lawyer in your province.
Looking for safe alternatives?
Browse certified-safe products in this category on Amazon Canada →
Get Canada's next recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CASL compliant · No spam · Unsubscribe anytime